Impact of pioglitazone on bone mineral density and bone marrow fat content

ConclusionsPioglitazone use for 12  months compared with placebo is associated with significant increase in BM fat content at the femoral neck, accompanied by a small but significant decrease in total hip BMD.

Source: Osteoporosis International - July 22, 2017 Category: Orthopaedics Source Type: research